4.8 Article

Enhanced Nose-to-Brain Delivery of Combined Small Interfering RNAs Using Lesion-Recognizing Nanoparticles for the Synergistic Therapy of Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Membrane-Fusion-Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy

Chunxiong Zheng et al.

Summary: A core-shell membrane-fusogenic liposome (MFL) was designed to reverse the immunosuppressive effects of tumor cell surface glycans and enhance tumor elimination through the presentation of NK-activating glycans. This was achieved by fusing the MFL with tumor cell membranes, delivering sialyltransferase-inhibitor-loaded cores into the cytoplasm to downregulate immunosuppressive sialic acid, and anchoring NK-activating-glycan-modified shells onto the tumor surface. The reprogrammed tumor surface resulted in NK activation and improved tumor susceptibility to NK-cell-mediated recognition and lysis.

ADVANCED MATERIALS (2023)

Article Biochemistry & Molecular Biology

Exosomes secreted from bone marrow mesenchymal stem cells suppress cardiomyocyte hypertrophy through Hippo-YAP pathway in heart failure

Yu Ren et al.

Summary: This study found that mesenchymal stem cell-derived exosomes have therapeutic potential in heart failure. The exosomes alleviate apoptosis and inflammatory response in cardiomyocytes by deactivating the Hippo-YAP pathway.

GENETICS AND MOLECULAR BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson's Disease

Huan Peng et al.

Summary: The treatment of Parkinson's disease has been hindered by complex pathologies and membrane barriers. A self-oriented nanocarrier called PR-EXO/PP@Cur, combining stem cell-derived exosomes with curcumin, can overcome these barriers and achieve threepronged synergistic treatment for PD. PR-EXO/PP@Cur shows great prospects for the treatment of PD and other neurodegenerative diseases.

ACS NANO (2022)

Review Pharmacology & Pharmacy

Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases

Weihong Ji et al.

Summary: Gene therapy has great potential in treating brain diseases, but faces challenges in delivery efficiency. Nature-inspired dynamic gene-loaded nanoassemblies (DGN) optimized for specific functions offer solutions to overcome barriers, such as crossing the blood-brain barrier and targeting cells efficiently. The utilization of DGN in brain disease treatment shows promise in meeting the requirements for effective gene therapy.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Chemistry, Multidisciplinary

Self-Catalytic Small Interfering RNA Nanocarriers for Synergistic Treatment of Neurodegenerative Diseases

Weihong Ji et al.

Summary: Self-catalytic nanocarriers, S/Ce-PABMS, are developed to catalyze delivery and treatment processes for synergistic treatment of neurodegenerative diseases. The nanocarriers facilitate cellular uptake and entry into neurons, while also scavenging reactive oxygen species and targeting SNCA to alleviate Parkinsonian pathology. Overall, these nanocarriers show great potential for the treatment of neurodegenerative diseases.

ADVANCED MATERIALS (2022)

Article Engineering, Biomedical

Cascaded Rocket Nanosystems with Spatiotemporal Separation for Triple-Synergistic Therapy of Alzheimer's Disease

Ruiyuan Liu et al.

Summary: A rocket delivery system based on metal ion/enzyme responses has been established for the treatment of Alzheimer's disease (AD). The system can target and penetrate the blood-brain barrier, effectively reducing the levels of amyloid-beta plaques, phosphorylated tau, and oxidative stress, thereby improving AD symptoms.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Nanoscience & Nanotechnology

BACE1 Aptamer-Modified Tetrahedral Framework Nucleic Acid to Treat Alzheimer's Disease in an APP-PS1 Animal Model

Yangyang Wang et al.

Summary: The tetrahedral framework nucleic acid can serve as a carrier to deliver the BACE1 aptamer to the brain, reducing the production of amyloid fi proteins. It also exhibits anti-apoptotic properties by reducing the production of reactive oxygen species, making it a potential drug for Alzheimer's disease.

ACS APPLIED MATERIALS & INTERFACES (2022)

Review Chemistry, Multidisciplinary

Exosomes-Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics

Rumiana Tenchov et al.

Summary: This article provides an overview of the applications of exosomes in therapeutics and diagnostics, analyzing their properties, isolation methods, clinical applications, and development pipelines. These studies contribute to the further development of the potential of exosomes in medical applications.

ACS NANO (2022)

Review Geriatrics & Gerontology

Emerging roles of oxidative stress in brain aging and Alzheimer's disease

Andra Ionescu-Tucker et al.

Summary: Reactive oxygen species (ROS) are metabolic byproducts that can be toxic at high levels and have been linked to cognitive aging and neurodegenerative diseases. Therapeutics like antioxidants, caloric restriction, and physical activity can reduce oxidation and prevent cognitive decline in brain aging and AD. Long term physical activity shows promise in improving cognitive health by reducing ROS levels and promoting optimal function.

NEUROBIOLOGY OF AGING (2021)

Article Biotechnology & Applied Microbiology

Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy

Yuan-Qiu Cheng et al.

Summary: The developed nanoscale coassembly shows potential for precise kidney hypoxia diagnosis and efficient kidney injury treatment, offering a functional platform to address multiple clinical needs.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Immunology

Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases

Ziwei Shen et al.

Summary: Research indicates that mesenchymal stem cell-derived exosomes (MSC-EXOs) have a significant inhibitory effect on effector cells involved in the immune response, and can be used to treat various autoimmune diseases, serving as a promising cell-free treatment strategy.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Traceable Nano-Biohybrid Complexes by One-Step Synthesis as CRISPR-Chem Vectors for Neurodegenerative Diseases Synergistic Treatment

Jie Shen et al.

Summary: This study successfully combines the CRISPR/Cas9 gene-editing tool with chemical drugs to inhibit the regeneration and eliminate disease-related proteins, showing significant improvement in cognitive abilities of 2xTg-AD mice. Additionally, the high relaxation rate of CF-TBIO provides accurate imaging signals, indicating its potential as a drug-delivery platform for neurodegenerative diseases therapy.

ADVANCED MATERIALS (2021)

Article Biochemistry & Molecular Biology

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer's Disease Pathology and Improve Cognitive Deficits

Yi-An Chen et al.

Summary: The study evaluated the therapeutic performance of MSC-exosomes in AD, showing that they could reduce Aβ expression, restore the expression of neuronal memory/synaptic plasticity-related genes, improve brain glucose metabolism and cognitive function in AD transgenic mice.

BIOMEDICINES (2021)

Article Medicine, Research & Experimental

Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

Yan Li et al.

Summary: The study utilized charge-switchable zwitterionic polycarboxybetaine (PCB) to load insulin and form PCB/insulin (PCB/INS) particles, which showed an opening effect on intestinal epithelium, increasing the intestinal permeability of insulin and enhancing the antidiabetic efficacy after oral administration.

THERANOSTICS (2021)

Article Biotechnology & Applied Microbiology

Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease

Chunhong Gao et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Review Biochemistry & Molecular Biology

Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

Lei Meng et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Review Clinical Neurology

Alzheimer's disease

C. A. Lane et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Chemistry, Multidisciplinary

Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease

Pengzhen Wang et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Article Biotechnology & Applied Microbiology

Overcoming cellular barriers for RNA therapeutics

Steven F. Dowdy

NATURE BIOTECHNOLOGY (2017)

Article Multidisciplinary Sciences

Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus

Qianfa Long et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform

Tom Haber et al.

SCIENTIFIC REPORTS (2017)

Article Chemistry, Multidisciplinary

In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles

Oshra Betzer et al.

ACS NANO (2017)

Article Chemistry, Multidisciplinary

Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery

Xin Liu et al.

ADVANCED MATERIALS (2016)

Article Biochemistry & Molecular Biology

Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail

Yu-Jen Chang et al.

ACS CHEMICAL NEUROSCIENCE (2016)

Article Chemistry, Multidisciplinary

Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries

Ester J. Kwon et al.

ACS NANO (2016)

Review Pharmacology & Pharmacy

Current status of non-viral gene therapy for CNS disorders

Rahul Dev Jayant et al.

EXPERT OPINION ON DRUG DELIVERY (2016)

Review Pharmacology & Pharmacy

Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier

Amirah E-E Aly et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Article Biochemistry & Molecular Biology

Astrocytes and neuroinflammation in Alzheimer's disease

Emma C. Phillips et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2014)

Review Biochemistry & Molecular Biology

Alzheimer's Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents

Houshang Amiri et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Review Pharmacology & Pharmacy

Exosomes for targeted siRNA delivery across biological barriers

Samir EL Andaloussi et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Review Clinical Neurology

Progress in gene therapy for neurological disorders

Michele Simonato et al.

NATURE REVIEWS NEUROLOGY (2013)

Editorial Material Biotechnology & Applied Microbiology

SiRNA delivery with exosome nanoparticles

Jasper G. van den Boorn et al.

NATURE BIOTECHNOLOGY (2011)

Review Genetics & Heredity

Current prospects for RNA interference-based therapies

Beverly L. Davidson et al.

NATURE REVIEWS GENETICS (2011)

Review Oncology

RNA interference in the clinic: challenges and future directions

Chad V. Pecot et al.

NATURE REVIEWS CANCER (2011)

Review Biochemistry & Molecular Biology

Neuronal caspase-3 signaling: not only cell death

M. D'Amelio et al.

CELL DEATH AND DIFFERENTIATION (2010)

Review Biotechnology & Applied Microbiology

Nonviral vectors for the delivery of small interfering RNAs to the CNS

Inmaculada Posadas et al.

NANOMEDICINE (2010)

Review Clinical Neurology

Astrocytes in Alzheimer's Disease

Alexei Verkhratsky et al.

NEUROTHERAPEUTICS (2010)

Article Biochemistry & Molecular Biology

Mechanism of okadaic acid-induced neuronal death and the effect of estrogens

Kun Don Yi et al.

JOURNAL OF NEUROCHEMISTRY (2009)